Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Arcadia Biosciences (RKDA) Return on Equity (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed Return on Equity for 11 consecutive years, with 0.34% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity fell 53.0% year-over-year to 0.34%, compared with a TTM value of 0.34% through Sep 2025, down 53.0%, and an annual FY2024 reading of 0.29%, down 24.0% over the prior year.
  • Return on Equity was 0.34% for Q3 2025 at Arcadia Biosciences, down from 0.14% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.2% in Q3 2024 and bottomed at 1.16% in Q2 2022.
  • Average Return on Equity over 5 years is 0.4%, with a median of 0.32% recorded in 2023.
  • The sharpest move saw Return on Equity soared 187bps in 2021, then tumbled -94bps in 2022.
  • Year by year, Return on Equity stood at 1.0% in 2021, then soared by 56bps to 0.44% in 2022, then skyrocketed by 87bps to 0.06% in 2023, then crashed by -469bps to 0.33% in 2024, then decreased by -1bps to 0.34% in 2025.
  • Business Quant data shows Return on Equity for RKDA at 0.34% in Q3 2025, 0.14% in Q2 2025, and 0.16% in Q1 2025.